Blue Trust Inc’s ARK Genomic Revolution ETF ARKG Stock Holding History

Blue Trust Inc’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-32	Closed	-$889	–	2540
2025 Q3	$889	Buy	+32	New	+$809	﹤0.01%	2348
2024 Q4	–	Sell	-267	Closed	-$6.27K	–	2462
2024 Q3	$6.27K	Hold	267	–	–	﹤0.01%	2342
2024 Q2	$7.68K	Hold	267	–	–	﹤0.01%	2029
2024 Q1	$7.68K	Hold	267	–	–	﹤0.01%	1515
2023 Q4	$7K	Hold	267	–	–	﹤0.01%	1694
2023 Q3	$9K	Hold	267	–	–	﹤0.01%	1428
2023 Q2	$8K	Hold	267	–	–	﹤0.01%	1365
2023 Q1	$8K	Sell	267 -228	-46%	-$7.07K	﹤0.01%	1652
2022 Q4	$16K	Hold	495	–	–	﹤0.01%	1367
2022 Q3	$15K	Hold	495	–	–	﹤0.01%	1191
2022 Q2	$22K	Buy	+495	New	+$17.3K	﹤0.01%	918

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Blue Trust Inc's ARKG Position: Q4 2025 in Review

Blue Trust Inc sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2025, closing a stake of 32 shares — an estimated $889 sold.

Blue Trust Inc first reported a position in ARKG in Q2 2022 and held it in 11 quarters. The position peaked at $22K in Q2 2022. 241 funds tracked by Wall St. Rank hold ARKG as of Q4 2025.

Blue Trust Inc reported no remaining ARK Genomic Revolution ETF position as of Q4 2025 after selling out during the quarter.
Blue Trust Inc sold 32 ARK Genomic Revolution ETF shares in Q4 2025, an estimated $889.
Blue Trust Inc first reported a position in ARK Genomic Revolution ETF in Q2 2022 and held it in 11 quarters.
Blue Trust Inc's ARK Genomic Revolution ETF position peaked at $22K in Q2 2022.
241 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2025.

Based on Blue Trust Inc's 13F filing for Q4 2025, filed 16 Jan 2026.